HearMate II is yet to gain approval from the Food and Drug Administration (FDA), but the Barnes-Jewish Hospital in Missouri has implanted it in Wilson Guthrie, a 61-year-old man from Kansas, suffering from end-stage heart failure.
He has since left for home, with that experimental heart-assist device that keeps his heart pumping.
Hospital officials said it's the longest stay the cardiothoracic ICU has had, and that a lot of technology was used to keep Wilson Guthrie alive.
"We're very excited to see him go home," Guthrie's sister, Teresa Rico, a family practitioner, said. "He's a lot better."
Guthrie was waiting at home for a heart transplant. But when his condition "profoundly deteriorated" last fall, he was airlifted to Barnes-Jewish for a temporary mechanical heart pump, "to see if he would turn around," his physician, Nader Moazami, said.
"I told the family he has a 90 percent chance of dying," said Moazami, surgical director of the hospital's and Washington University School of Medicine's heart transplant and artificial heart programs.
First the regular mechanical pump was tried out. It is an external device that can only be used in an ICU and is intended to support a patient for a month or two. Over the next few months, his liver function and breathing recovered enough that Guthrie was ready for the next step. But what?
He was reconsidered for a transplant, but with his kidneys still in failure and with intermittent internal bleeding, he was disqualified. The temporary pump kept him captive to the ICU.
Guthrie's small stature made him unsuitable for larger heart pumps, which would not have fit into his body.
The only option was the smaller HeartMate II pump, which wasn't approved by the FDA, and Guthrie's insurance company wouldn't pay for it initially.
Through a series of letters and phone calls to the FDA and Humana Health CarPage: 1 2 Related medicine news :1
. One in Three Heart Attack Patients Have No Chest Pains
. Amphetamines Help Recovery of Stroke Patients
. Painkillers Do Not Shorten Dying Patients Lives
. Patients With Filariasis More Prone To HIV Infection5
. Glivec - New Hope For CMC Patients6
. Patient’s perception of health status helps in better recover7
. Patients often assume wrongly that they are allergic to penicillin8
. New FDA Approved Drug NATRECOR For Heart Failure Patients9
. Hemochromatosis Patients Blood is Safe 10
. Fifth US Patient Receives Artificial Heart
. Patients Pressure Would Result In Overprescription